Pheton Holdings Ltd (NASDAQ:PTHL) Short Interest Update

Pheton Holdings Ltd (NASDAQ:PTHL) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 17,067 shares, a decrease of 29.4% from the December 15th total of 24,161 shares. Based on an average daily trading volume, of 68,493 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the company’s stock are sold short. Approximately 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 68,493 shares, the short-interest ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Pheton in a research note on Friday, October 31st. Wall Street Zen upgraded Pheton from a “sell” rating to a “hold” rating in a research note on Sunday, September 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Pheton has an average rating of “Sell”.

Pheton Price Performance

NASDAQ PTHL opened at $0.92 on Friday. Pheton has a 52-week low of $0.39 and a 52-week high of $32.00. The firm has a 50-day moving average price of $0.54 and a 200 day moving average price of $3.63.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.